Bio


I was born in Oregon and raised in Iowa, where I cultivated my initial interest in science and medicine. I completed my undergraduate degree and medical school at the University of Iowa before heading to Stanford University for my internal medicine residency and oncology fellowship training. I chose this field to try my best in assisting patients during times of great need, and working to understand what is of greatest importance to them as they navigate their unique journey of cancer care. My scholarly interests include exploring both the efficacy and costs of novel cancer therapeutics, identifying important issues in patient survivorship, and promoting strength in medical education.

Clinical Focus


  • Fellow
  • Hematology
  • Oncology

Honors & Awards


  • Timothy F. Beckett, Jr. Award for Best Clinical Teaching by a Medicine Fellow, Stanford University School of Medicine, Department of Internal Medicine (2018)
  • Award for Best Clinical Teaching by a Medicine Resident, Stanford University School of Medicine, Department of Internal Medicine (2017)
  • Charles Dorsey Armstrong Award for Clinical Excellence in Patient Care, Stanford University School of Medicine, Department of Internal Medicine (2017)
  • Julian Wolfsohn Award for Outstanding Performance in Internal Medicine, Stanford University School of Medicine, Department of Internal Medicine (2017)
  • Medical Student Education Award, Stanford University School of Medicine (2015)
  • William R. Wilson Award for Outstanding Performance in Internal Medicine by a Senior Medical Student, Carver College of Medicine, University of Iowa (2014)

Boards, Advisory Committees, Professional Organizations


  • Member, American Society of Clinical Oncology (2017 - Present)
  • Member, American Society of Hematology (2016 - Present)
  • Member, American College of Physicians (2014 - Present)

Professional Education


  • Residency, Stanford University, Internal Medicine (2017)
  • MD, Carver College of Medicine, University of Iowa (2014)
  • BS, University of Iowa, Biomedical Engineering (2010)

All Publications


  • An Electronic Best Practice Alert Based on Choosing Wisely Guidelines Reduces Thrombophilia Testing in the Outpatient Setting. Journal of general internal medicine Jun, T., Kwang, H., Mou, E., Berube, C., Bentley, J., Shieh, L., Hom, J. 2018

    View details for DOI 10.1007/s11606-018-4663-8

    View details for PubMedID 30215176

  • The Power of Trust. JAMA oncology Mou, E., Schapira, L., Kunz, P. 2018

    View details for DOI 10.1001/jamaoncol.2018.0495

    View details for PubMedID 29710067

  • Trust in neuroendocrine tumors: The importance of communication in rare and chronic malignancies Mou, E., Wittenberg, T. A., Kunz, P. L., Schapira, L. AMER SOC CLINICAL ONCOLOGY. 2018
  • Magnitude of Potentially Inappropriate Thrombophilia Testing in the Inpatient Hospital Setting. Journal of hospital medicine Mou, E., Kwang, H., Hom, J., Shieh, L., Kumar, A., Richman, I., Berube, C. 2017; 12 (9): 735–38

    Abstract

    Laboratory costs of thrombophilia testing exceed an estimated $650 million (in US dollars) annually. Quantifying the prevalence and financial impact of potentially inappropriate testing in the inpatient hospital setting represents an integral component of the effort to reduce healthcare expenditures. We conducted a retrospective analysis of our electronic medical record to evaluate 2 years' worth of inpatient thrombophilia testing measured against preformulated appropriateness criteria. Cost data were obtained from the Centers for Medicare and Medicaid Services 2016 Clinical Laboratory Fee Schedule. Of the 1817 orders analyzed, 777 (42.7%) were potentially inappropriate, with an associated cost of $40,422. The tests most frequently inappropriately ordered were Factor V Leiden, prothrombin gene mutation, protein C and S activity levels, antithrombin activity levels, and the lupus anticoagulant. Potentially inappropriate thrombophilia testing is common and costly. These data demonstrate a need for institution-wide changes in order to reduce unnecessary expenditures and improve patient care.

    View details for PubMedID 28914278

  • Prevalence and Financial Impact of Inappropriate Thrombophilia Testing in the Inpatient Hospital Setting: A Retrospective Analysis Mou, E., Kwang, H., Hom, J., Shieh, L., Ahuja, N., Harman, S., Johnson, T., Kumar, A., Shah, N., Witteles, R., Berube, C. AMER SOC HEMATOLOGY. 2016